Arcellx (ACLX) Retained Earnings (2021 - 2025)
Arcellx (ACLX) recorded quarterly Retained Earnings of $843000.0 in Q4 2025, up 100.13% quarter-over-quarter from -$667.6 million in Q3 2025, and up 100.17% on a YoY basis from $421142.7 in Q4 2024.
Arcellx (ACLX) Retained Earnings (2021 - 2025) Analysis & Trends
Arcellx's Retained Earnings history runs 5 years deep, the most recent figure standing at $843000.0 for Q4 2025.
- In Q4 2025, Retained Earnings rose 100.17% year-over-year to $843000.0; the TTM figure through Dec 2025 stood at $843000.0 (up 100.17% YoY), while the FY2025 annual figure was $843000.0, up 100.17% from the prior year.
- Retained Earnings was $843000.0 for Q4 2025 at Arcellx, up from -$667.6 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.9 million in Q3 2024 to a low of -$667.6 million in Q3 2025.
- Historically, Retained Earnings has averaged -$165.1 million across 5 years, with a median of -$512000.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings soared 347.51% in 2023, then slumped 90927.79% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$20000.0 in 2021, then slumped by 1005.0% to -$221000.0 in 2022, then jumped by 347.51% to $547000.0 in 2023, then plunged by 90927.79% to -$496.8 million in 2024, then surged by 100.17% to $843000.0 in 2025.
- The last three Retained Earnings figures came in at $843000.0 (Q4 2025), -$667.6 million (Q3 2025), and -$611.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 843,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 843,000.00 |
| Sep 30, 2025 | -667.65 Mn |
| Jun 30, 2025 | -611.87 Mn |
| Mar 31, 2025 | 649,000.00 |
| Dec 31, 2024 | -496.83 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | -792,000.00 |
| Mar 31, 2024 | -512,000.00 |
| Dec 31, 2023 | 547,000.00 |
| Sep 30, 2023 | -409.32 Mn |
| Jun 30, 2023 | -7,000.00 |
| Mar 31, 2023 | 86,000.00 |
| Dec 31, 2022 | -221,000.00 |
| Sep 30, 2022 | -279.80 Mn |
| Jun 30, 2022 | -186.92 Mn |
| Mar 31, 2022 | -156.15 Mn |
| Dec 31, 2021 | -20,000.00 |